Abstract
To deal with the changing health care landscape and the expanding growth of specialty pharmaceuticals, it is imperative that health systems evaluate their current structure of providing hospitalbased specialty pharmacy services. Specialty pharmacy services have rapidly expanded over the last decade, and this has affected a wide variety of disease states and in many cases has dramatically enhanced clinical outcomes. However, these medications come at a substantial cost, and a clear plan must be established at each institution to sustain financial viability. By focusing on developing a plan for specialty pharmaceuticals, the pharmacy director can help ensure the institution has prepared a strategy that is conservative, financially viable, and patient-centered.